Company profile: NIL Technology
1.1 - Company Overview
Company description
- Provider of optical solutions designing, developing, and manufacturing optical elements and components. Services include optical design of modules, meta-optical and diffractive elements; metalens prototyping for NIR/SWIR/VIS using electron beam lithography; optical testing in Denmark and Switzerland; micro/nanostructuring and high-volume replication via UV-curable or thermoplastic processes for mass production.
Products and services
- Mass Production: NILT produces optical elements and components using high-quality masters and approved processes, delivering consistent high quality and reliability in industrial-grade series fabrication
- Metalens Prototyping: NILT engineers Meta Optical Elements (MOE) for NIR/SWIR/VIS with fast turnaround, utilizing electron beam lithography and post-processing in custom-engineered prototypes
- Micro and Nanostructuring: NILT fabricates using micro and nano replication technologies, starting from a master defined by electron beam lithography and dry etching for nano-scale patterning
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NIL Technology
Magnetic Insight
HQ: United States
Website
- Description: Provider of preclinical magnetic particle imaging solutions for cellular imaging to measure cancer immunotherapy efficacy, including Momentum CT, an MPI imager with integrated X-ray/CT for high sensitivity and resolution in vivo imaging; VivoTrax and VivoTrax Plus tracers for cell, vascular and lymph node imaging; Relax software to predict nanoparticle imaging behavior; and MagImage for 2D/3D visualization, co-registration, and advanced data analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Magnetic Insight company profile →
Genisphere
HQ: United States
Website
- Description: Provider of nanotechnology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genisphere company profile →
Kontem
HQ: Germany
Website
- Description: Provider of phase contrast systems for transmission electron microscopes that significantly improve image quality, especially for biological applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kontem company profile →
2C Tech
HQ: United States
Website
- Description: Provider of quantum dot-based nanotechnology for retinal degenerative diseases, delivering photovoltaic stimulation to the retina via intravitreal injection to activate photoreceptors, preserve or enhance vision, and potentially treat Retinitis Pigmentosa and Macular Degeneration, with neuroprotective effects on neuro-retinal cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 2C Tech company profile →
Topas Therapeutics
HQ: Germany
Website
- Description: Provider of nanoparticle-based therapeutics and the Topas Particle Conjugates platform to induce antigen-specific immune tolerance by harnessing the liver’s tolerogenic power, targeting autoimmune and antigen-driven diseases (including allergies and anti-drug antibodies), with clinical candidates TPM203 (Phase 1) for pemphigus vulgaris and TPM502 (Phase 2) for celiac disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Topas Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NIL Technology
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NIL Technology
2.2 - Growth funds investing in similar companies to NIL Technology
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NIL Technology
4.2 - Public trading comparable groups for NIL Technology
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →